Response to "Comment on 'Consulting the consultants: Avastin in the treatment of wet AMD'".
作者信息
Mohamed R, Saunders D C, Mathews J P
机构信息
Department of Ophthalmology, Abergele Hospital, Llanfair Rd, Abergele, LL22 8DP, UK.
出版信息
Eye (Lond). 2019 Nov;33(11):1822. doi: 10.1038/s41433-019-0533-9. Epub 2019 Jul 31.
Abstract
摘要
相似文献
1
Response to "Comment on 'Consulting the consultants: Avastin in the treatment of wet AMD'".对《关于“咨询专家：阿瓦斯汀治疗湿性年龄相关性黄斑变性”的评论》的回应
Eye (Lond). 2019 Nov;33(11):1822. doi: 10.1038/s41433-019-0533-9. Epub 2019 Jul 31.
2
Comment on 'Consulting the consultants: Avastin in the treatment of wet AMD'.对《咨询专家：阿瓦斯汀治疗湿性年龄相关性黄斑变性》的评论
Eye (Lond). 2019 Nov;33(11):1821. doi: 10.1038/s41433-019-0532-x. Epub 2019 Jul 29.
3
Consulting the consultants: Avastin in the treatment of wet AMD.咨询专家：阿瓦斯汀治疗湿性年龄相关性黄斑变性
Eye (Lond). 2019 Apr;33(4):529-531. doi: 10.1038/s41433-018-0260-7. Epub 2018 Nov 5.
4
Consulting the patients: Avastin in the treatment of Wet AMD (Part II).咨询患者：阿瓦斯汀治疗湿性年龄相关性黄斑变性（第二部分）
Eye (Lond). 2019 Jun;33(6):871-873. doi: 10.1038/s41433-019-0366-6. Epub 2019 Feb 13.
5
A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab.抗血管内皮生长因子药物治疗新生血管性年龄相关性黄斑变性的疗效和安全性结局的系统评价：雷珠单抗和贝伐单抗的比较。
Curr Med Res Opin. 2011 Jul;27(7):1465-75. doi: 10.1185/03007995.2011.585394. Epub 2011 May 31.
6
Ranibizumab (Lucentis) versus Bevacizumab (Avastin) for the Treatment of Age-Related Macular Degeneration: An Economic Disparity of Eye Health.雷珠单抗（Lucentis）与贝伐单抗（Avastin）治疗年龄相关性黄斑变性：眼部健康的经济差异
Semin Ophthalmol. 2016;31(4):378-84. doi: 10.3109/08820538.2016.1154174. Epub 2016 Apr 26.
7
Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.贝伐单抗（阿瓦斯汀）治疗年龄相关性黄斑变性和脉络膜新生血管的色素上皮脱离的预后意义。
Retina. 2011 Oct;31(9):1812-8. doi: 10.1097/IAE.0b013e31821987a4.
8
Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin(®) ) in neovascular age-related macular degeneration.超声评估新生血管性年龄相关性黄斑变性患者玻璃体内注射贝伐单抗（阿瓦斯汀®）的短期眼部血管效应。
Acta Ophthalmol. 2010 Sep;88(6):641-5. doi: 10.1111/j.1755-3768.2009.01526.x.
9
Off-label use of bevacizumab for wet age-related macular degeneration in Europe.贝伐单抗在欧洲用于湿性年龄相关性黄斑变性的标签外使用。
Graefes Arch Clin Exp Ophthalmol. 2020 Mar;258(3):503-511. doi: 10.1007/s00417-019-04569-8. Epub 2019 Dec 30.
本文引用的文献
1
Comment on 'Consulting the consultants: Avastin in the treatment of wet AMD'.对《咨询专家：阿瓦斯汀治疗湿性年龄相关性黄斑变性》的评论
Eye (Lond). 2019 Nov;33(11):1821. doi: 10.1038/s41433-019-0532-x. Epub 2019 Jul 29.
2
Consulting the patients: Avastin in the treatment of Wet AMD (Part II).咨询患者：阿瓦斯汀治疗湿性年龄相关性黄斑变性（第二部分）
Eye (Lond). 2019 Jun;33(6):871-873. doi: 10.1038/s41433-019-0366-6. Epub 2019 Feb 13.
3
Consulting the consultants: Avastin in the treatment of wet AMD.咨询专家：阿瓦斯汀治疗湿性年龄相关性黄斑变性
Eye (Lond). 2019 Apr;33(4):529-531. doi: 10.1038/s41433-018-0260-7. Epub 2018 Nov 5.
Zotero 插件